CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Clinical trials for CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA explained in plain language.
Never miss a new study
Get alerted when new CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA trials appear
Sign up with your email to follow new studies for CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare heart condition: AGP100 drug trial begins
Disease control Recruiting nowThis study tests a new drug, AGP100, in 10 adults with a rare inherited heart condition called CPVT, which causes dangerous fast heartbeats during stress or exercise. Participants take three different doses of AGP100 over six weeks while continuing their usual heart medications. …
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Phase: PHASE2 • Sponsor: Agiana Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 09:55 UTC
-
New drug aims to calm deadly heart rhythm in rare genetic disorder
Disease control Recruiting nowThis study tests an experimental drug called CRD-4730 in 12 adults with a rare inherited heart condition (CPVT) that can cause dangerously fast heartbeats during exercise or stress. Participants will receive two different doses of the drug and a placebo in random order to see if …
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Phase: PHASE2 • Sponsor: Cardurion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 09:34 UTC
-
Gene therapy aims to calm deadly heart rhythm disorder in first human test
Disease control Recruiting nowThis early-stage study tests the safety of a single dose of SGT-501, a gene therapy for people with catecholaminergic polymorphic ventricular tachycardia (CPVT), a rare inherited heart condition that can cause dangerous heart rhythms during exercise or stress. Up to 18 adults and…
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Phase: PHASE1 • Sponsor: Solid Biosciences Inc. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Brazil launches massive heart gene hunt to uncover hidden risks
Knowledge-focused Recruiting nowThis study is creating a registry of 1,211 people in Brazil who have inherited heart conditions like cardiomyopathy, arrhythmias, or Marfan syndrome. Researchers will collect DNA samples and medical information to find out which genes are most commonly affected and how often thes…
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Sponsor: Hospital do Coracao • Aim: Knowledge-focused
Last updated May 26, 2026 09:34 UTC